Evidence map›Paper›PMID 42701518›Full record

ArticleAcute medicine & surgery

Clinical and Microbiological Characteristics of Invasive Group A Streptococcus Infection: Four Case Series of Re-Emerging Pathogens.

Shuji Okahara, Shinnosuke Fukushima, Yuto Hamaguchi, Masanobu Hishiike, Yohei Motoi, Kazuyoshi Gotoh, Shuma Tsuji, Koji Iio, Hideharu Hagiya

Abstract read
In one paragraph

Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuji OkaharaDepartment of Intensive Care Okayama University Hospital Okayama Japan.ORCID https://orcid.org/0000-0003-1188-158X
Shinnosuke FukushimaDepartment of Bacteriology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan.ORCID https://orcid.org/0000-0003-4871-4996
Yuto HamaguchiDepartment of Anesthesiology and Resuscitology Okayama University Hospital Okayama Japan.
Masanobu HishiikeDepartment of Anesthesiology and Resuscitology Okayama University Hospital Okayama Japan.
Yohei MotoiDepartment of Anesthesiology and Resuscitology Okayama University Hospital Okayama Japan.
Kazuyoshi GotohDepartment of Medical Laboratory Science Okayama University Graduate School of Health Sciences Okayama Japan.ORCID https://orcid.org/0000-0003-1042-8492
Shuma TsujiDepartment of Medical Laboratory Science Okayama University Graduate School of Health Sciences Okayama Japan.
Koji IioMicrobiology Division, Clinical Laboratory Okayama University Hospital Okayama Japan.
Hideharu HagiyaDepartment of Infectious Diseases Okayama University Hospital Okayama Japan.ORCID https://orcid.org/0000-0002-5086-1891

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Group A Methods: We retrospectively reviewed four consecutive iGAS cases requiring intensive care between March and May 2024. Detailed clinical, microbiological, and genomic investigations were performed to characterize the causative strains and their associated virulence profiles. Results: All patients required respiratory and/or circulatory support with surgical debridement. Three cases involved necrotizing fasciitis, and one involved intra-abdominal infection secondary to ovarian tumor rupture. All four patients received penicillin G and clindamycin as definitive antimicrobial therapy, with two developing severe drug-related adverse events. Genotypic analysis identified three isolates as Conclusion: This case series documents the identification of the M1UK lineage among critically ill patients with iGAS infections in Japan. Our findings support the need for continued molecular surveillance while reinforcing the importance of prompt surgical source control and appropriate antimicrobial therapy in the management of severe iGAS.

Indexed as

emm typeGroup A StreptococcusM1UK strainnecrotizing fasciitisStreptococcus pyogenes

Identifiers

PMID42701518
PMCPMC13545505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.